These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29373841)

  • 21. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use.
    Parashar D; Rajendran V; Shukla R; Sistla R
    Eur J Pharm Sci; 2020 Jan; 142():105159. PubMed ID: 31747618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
    Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
    J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. siRNA applications in nanomedicine.
    Tokatlian T; Segura T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(3):305-15. PubMed ID: 20135697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical and clinical development of siRNA-based therapeutics.
    Ozcan G; Ozpolat B; Coleman RL; Sood AK; Lopez-Berestein G
    Adv Drug Deliv Rev; 2015 Jun; 87():108-19. PubMed ID: 25666164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances of siRNA delivery by nanoparticles.
    Yuan X; Naguib S; Wu Z
    Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery.
    Li Y; Gao J; Zhang C; Cao Z; Cheng D; Liu J; Shuai X
    Top Curr Chem (Cham); 2017 Apr; 375(2):27. PubMed ID: 28194746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient tuning of siRNA dose response by combining mixed polymer nanocarriers with simple kinetic modeling.
    Greco CT; Muir VG; Epps TH; Sullivan MO
    Acta Biomater; 2017 Mar; 50():407-416. PubMed ID: 28063990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.